Uretero1
Payments companies reported to CMS as associated with Uretero1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Uretero1, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Uretero1
These are the largest totals companies reported as associated with Uretero1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Brewer | Homewood, AL | Urology | $262.92 |
| Nicholas Pickersgill | New York, NY | Urology | $160.50 |
| Noah Frydenlund | Chicago, IL | Urology | $160.50 |
| Haim Herzberg | New York, NY | Urology | $160.50 |
| Viranda Jayalath | New York, NY | Urology | $160.50 |
| Samuel Gold | New York, NY | Urology | $160.50 |
| Muhammad Alkazemi | Saint Louis, MO | Urology | $160.50 |
| Dicken Ko | Providence, RI | Urology | $123.26 |
| Wesley Porta | Baton Rouge, LA | Urology | $54.05 |
| Meredith Rosenzweig | Baton Rouge, LA | Urology | $54.05 |
Prescribed Uretero1?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.